Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study
Authors:
- the Centre for Brain Health in HIV/AIDSTHthe Centre for Brain Health in HIV/AIDS
- Adriana CarvalhalACAdriana Carvalhal
- M. John GillMGM. John Gill
- Tsegaye BekeleTBTsegaye Bekele
- 16 November 2015
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 22 (3) , 349-357
Abstract
Since the introduction of combination antiretroviral therapy (cART), the incidence of severe HIV-associated neurocognitive impairment has declined significantly, whereas the prevalence of the milder forms has increased. Studies suggest that better distribution of cART drugs into the CNS may be important in reducing viral replication in the CNS and in reducing HIV-related brain injury. Correlates of neuropsychological (NP) performance were determined in 417 participants of the Ontario HIV Treatment Cohort Study (OCS). All participants were on three cART drugs for at least 90 days prior to assessment. Multiple logistic and linear regression methods were used. Most participants were Caucasian men with mean age of 47 years. About two thirds had a nadir CD4+ T-cell count below 200 cells/μL and 92 % had an undetectable plasma HIV viral load. The median CNS penetration effectiveness (CPE) score was 7. Sixty percent of participants had neuropsychological impairment. Higher CPE values significantly correlated with lower prevalence of impairment in bivariate and multivariate analyses. In this cross-sectional analysis of HIV+ adults who had a low prevalence of comorbidities and were taking three-drug cART regimens, greater estimated distribution of cART drugs into the CNS was associated with better NP performance.Keywords
This publication has 56 references indexed in Scilit:
- Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDSAIDS, 2013
- Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test–Revised, Brief Visuospatial Memory Test–Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card VersionJournal of Clinical and Experimental Neuropsychology, 2011
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohortAIDS, 2011
- Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy VolunteersNeuropsychopharmacology, 2010
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceAIDS, 2009
- HIV-Associated Episodic Memory Impairment: Evidence of a Possible Differential Deficit in Source Memory for Complex Visual StimuliThe Journal of Neuropsychiatry and Clinical Neurosciences, 2009
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- HIV-associated prospective memory impairment increases risk of dependence in everyday functioning.Neuropsychology, 2008
- Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest ReliabilityThe Clinical Neuropsychologist, 1998
- The CES-D ScaleApplied Psychological Measurement, 1977